Cefoxazole

This classification denotes a cephalosporin antibiotic with the molecular formula C21H18ClN3O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) BN10X2TL6I, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetoxy)methyl)-7-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-8-oxo-, (6r-trans)- but more generally known as cefoxazole, which bears US NIH Compound Identifier 65798. European Medicines Agency schedules Cefoxazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07408MIG. The term CEFOXAZOLE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 30, No. 10 1976, List 16). CEFOXAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cefoxazole under HS 29419000 and SITC 54139. As of Q4 2014, CEFOXAZOLE remains US FDA's Preferred Term for this commodity. Cefoxazole bears US NLM identifiers UMLS ID C0055084 and NCI Concept Code C76171. SMILES: CLC1C(C2NOC(C2C(=O)NC2C3SCC(=C(N3C2=O)C(=O)O)COC(=O)C)C)CCCC1.